Cui-Yun  Yu

Prof. Cui-Yun Yu


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2020 in Acta Biomaterialia
Verified
Journal Article
Closed access
CXCheng-Hui Xu
Cheng-Hui Xu
PYPeng-Ju Ye
Peng-Ju Ye
YZYang-Chun Zhou
Yang-Chun Zhou
DHDong-Xiu He
Dong-Xiu He
HWHua Wei
Hua Wei
CYCui-Yun Yu
Cui-Yun Yu

1 July 2021 in Journal of Controlled Release
Verified
Journal Article
Closed access
ZZZhi Zheng
Zhi Zheng
YTYing Tan
Ying Tan
YLYi Li
Yi Li
YLYing Liu
Ying Liu
GYGuang hui Yi
Guang hui Yi
HWHua Wei
Hua Wei

30 January 2024 in Biomaterials Science
Verified
Journal Article
Closed access
PDF file
YCYao Cheng
Yao Cheng
HZHaitao Zhang
Haitao Zhang
HWHua Wei
Hua Wei
CYCui-Yun Yu
Cui-Yun Yu
Tumor therapy continues to be a prominent field within biomedical research. The development of various drug carriers has been propelled by concerns surrounding the side effects and targeting efficacy of various chemotherapeutic drugs and other therapeutic agents. These carriers strive to enhance drug concentration at tumor sites, minimize systemic side effects, and improve therapeutic outcomes. Among the reported delivery systems, injectable hydrogels have emerged as an emerging candidate for the in vivo delivery of chemotherapeutic drugs due to their minimal invasive drug delivery properties. This review systematically summarizes the composition and preparation methodologies of injectable hydrogels and further highlights the delivery mechanisms of diverse drugs using these hydrogels for tumor therapy, along with an in-depth discussion on the optimized therapeutic efficiency of drugs encapsulated within the hydrogels. The work concludes by providing a dynamic forward-looking perspective on the potential challenges and possible solutions of the in situ injectable hydrogels for non-surgical and real-time diagnostic applications.

14 September 2022 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
SLShao-Yang Lv
Shao-Yang Lv
SHSuisui He
Suisui He
XLXiao-Li Ling
Xiao-Li Ling
YWYue-Qin Wang
Yue-Qin Wang
CHCong Huang
Cong Huang
CYCui-Yun Yu
Cui-Yun Yu

25 February 2019 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
QNQian Ning
Qian Ning
YLYu-Feng Liu
Yu-Feng Liu
PYPeng-Ju Ye
Peng-Ju Ye
PGPei Gao
Pei Gao
ZLZhi-Ping Li
Zhi-Ping Li
CYCui-Yun Yu
Cui-Yun Yu

31 May 2019 in Frontiers in Chemistry
Verified
Journal Article
Open access
PDF file
HTHuaxin Tan
Huaxin Tan
TWTaoyu Wang
Taoyu Wang
YSYaru Shao
Yaru Shao
CYCui-Yun Yu
Cui-Yun Yu
LHLidan Hu
Lidan Hu
Persistent luminescence is a phenomenon in which luminescence is maintained for minutes to hours without an excitation source. Owing to their unique optical properties, various kinds of persistent luminescence materials (PLMs) have been developed and widely employed in numerous areas, such as bioimaging, phototherapy, data-storage, and security technologies. Due to the complete separation of two processes, —excitation and emission—, minimal tissue absorption, and negligible autofluorescence can be obtained during biomedical fluorescence imaging using PLMs. Rechargeable PLMs with super long afterglow life provide novel approaches for long-term phototherapy. Moreover, owing to the exclusion of external excitation and the optical rechargeable features, multicolor PLMs, which have higher decoding signal-to-noise ratios and high storage capability, exhibited an enormous application potential in information technology. Therefore, PLMs have significantly promoted the application of optics in the fields of multimodal bioimaging, theranostics, and information technology. In this review, we focus on the recently developed PLMs, including inorganic, organic and inorganic-organic hybrid PLMs to demonstrate their superior applications potential in biomedicine and information technology.